Figure 4.Somatic mutations in 171 patients treated by surgery and adjuvant chemotherapy. (A) Co-occurring and exclusive genes in mutation profiles. (B) Potential druggable gene categories and top five involved genes. (C) Enrichment of known oncogenic signaling pathways in patients with gastric cancer (D).
